IFL Enterprises (540377)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1.2 |
| Market Cap | ₹90.37 Cr |
| P/E Ratio | 5.91 |
| ROCE | 7.27% |
| ROE | 11.15% |
| Dividend Yield | 0% |
| Profit Growth | -185.37% |
| Debt/Equity | — |
| Sales Growth | -100% |
| 52-Week Range | ₹0.3 — ₹1.2 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹0.63 |
Strengths
- Positive book value of ₹0.63 per share provides a small asset cushion.
- Reported historical ROE of 11.15% suggests the company once generated decent returns on equity.
- Small market cap of ₹90 Cr means even a modest operational recovery could move per-share earnings significantly.
- ROCE of 7.27% indicates some past capital productivity, though it is currently not meaningful with zero sales.
Concerns
- Latest quarter revenue is ₹0 Cr and sales growth is -100%, so the business is currently not generating sales.
- Profit growth of -185.37% and a negative quarterly net profit make the reported P/E of 5.91 unreliable.
- P/B of 1.90 means paying a premium to book value for a company with no visible earning power.
- Piotroski F-Score of 3/9 and missing promoter/debt data point to weak fundamentals and poor transparency.
AI Analysis
Imagine buying a trading company that currently has no sales. IFL Enterprises' latest quarter shows ₹0 Cr of revenue and a marginal net loss, and trailing sales growth is -100%. That alone tells me this is not a going concern in any normal sense. The reported P/E of 5.91 is little more than a historical artefact; with profit growth at -185.37%, current earnings are negative, so an earnings multiple is meaningless. Graham would ask: what am I really buying? Book value is ₹0.63 per share, but I am being asked to pay ₹1.20, or 1.9 times book, for a franchise that has stopped producing. The reported ROE of 11.15% and ROCE of 7.27% are backward-looking; they do not compensate for a collapsing top line. The Piotroski F-Score of 3 out of 9 strengthens my suspicion: the fundamentals are deteriorating, not healing. There is no dividend, promoter holding is not disclosed, and debt/equity data is absent, leaving me with poor visibility. The stock has already run from ₹0.30 to its 52-week high of ₹1.20, so the market appears to be pricing a hopeful revival. As a value investor, I need evidence, not hope. I would only consider this a speculative turnaround candidate if sales reappear and profits turn positive, and even then the price must offer a margin of safety below intrinsic value. Today, at 1.9 times book with zero revenue, I see no margin of safety. I would keep it on a watchlist, not in a portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer